Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911087
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-20
First Post:
2023-06-18
Brief Title:
A Phase IIIII Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2
Sponsor:
Organization:
Stemirna Therapeutics